Track this trial free. DataLookout checks ClinicalTrials.gov daily and emails you which fields changed on NCT06810999 (status, enrollment, completion dates, endpoints, sites) when this record is updated. Free accounts track up to 5 trials.

Track this trial

From Fear to Purpose ACT Protocol. Implications of Death Anxiety in Depression and Anxiety Symptoms.

StatusNot Yet Recruiting
PhaseNot applicable
Started
View on ClinicalTrials.gov ↗
Record status
This record was last updated April 18, 2025 (before its estimated December 30, 2025 completion). Its status may not reflect the trial's current state.

Record History

See every version on ClinicalTrials.gov ↗

  1. Start date: Mar 1, 2025 to Jun 1, 2025
    • Primary completion date: Jul 30, 2025 to Dec 30, 2025
    • Study completion date: Aug 30, 2025 to Dec 30, 2025
    v3
  2. Enrollment target: 100 to 175v2 Show 6 more changesShow less
    • Primary completion date: Mar 30, 2025 to Jul 30, 2025
    • Study completion date: Oct 30, 2025 to Aug 30, 2025
    • Start date: Feb 1, 2025 to Mar 1, 2025
    • Eligibility criteria expanded, about 17 words
    • Secondary endpoints revised (6)
    • Study description shortened, about 8 words
  3. Study First Submitted
  • Stopped: an ongoing trial was terminated, suspended or withdrawn.
  • Notable: the trial’s plan changed such as a big move in its timeline or size, a new primary endpoint, sponsor or phase, or recruiting opened or resumed.
  • Minor: routine progress and housekeeping, such as sites added or enrollment closed.
Babes-Bolyai University
13 trials monitored
See 1 trial at risk
Anxiety
3,263 trials monitored
See 159 trials at risk
Depression
3,055 trials monitored
See 173 trials at risk
The main purpose of this placebo controlled trial is to test the efficacy of a one-session From Fear to Purpose ACT intervention in reducing self-reported death anxiety levels. Another objective of this study is to investigate whether reductions in death anxiety levels are associated with reductions in depression and anxiety levels, thus testing if death anxiety is a transdiagnostic factor involved in psychopathology.
Trial Details
NCT Number NCT06810999
Lead Sponsor Babes-Bolyai University
Conditions
(from sponsor)		 Death Anxiety, Depression, Anxiety
Related terms Anxiety Disorders, Depression, Necrophobia
Enrollment 175 participants
Start Date
Primary Completion (estimated)
Study Completion (estimated)
Updated on ClinicalTrials.gov